IRDiRC

From Bioblast


high-resolution terminology - matching measurements at high-resolution


IRDiRC

Description

IRDiRC.png The International Rare Diseases Research Consortium (IRDiRC) teams up researchers and organizations investing in rare diseases research in order to achieve two main objectives by the year 2020, namely to deliver 200 new therapies for rare diseases and means to diagnose most rare diseases.

Abbreviation: IRDiRC

Reference: IRDiRC



MitoPedia topics: MitoGlobal Organizations 


The organization's goals

A number of grand challenges are being addressed through collaborative actions to reach these 2020 goals such as:

  • establishing and providing access to harmonized data and samples,
  • performing the molecular and clinical characterization of rare diseases,
  • boosting translational, preclinical and clinical research,
  • and streamlining ethical and regulatory procedures.


Contact details

Chairman

Christopher P. Austin



Members of the Scientific Committees


Diagnostics Scientific Committee (DSC)

Kym Boycott (Chair)
Gareth Baynam (Vice Chair)

Interdisciplinary Scientific Committee (ISC)

Petra Kaufmann (Chair)
Domenica Taruscio (Vice Chair)

Therapies Scientific Committee (TSC)

Diego ArdigΓ² (Chair)
Virginie Hivert (Vice-Chair)



Business address

IRDiRC – Inserm US14
Plateforme Maladies Rares | Rare Diseases Platform
96 rue Didot, France
75014 Paris
E-mail: contact@irdirc.org
Tel: +33 1 56 53 81 37
Fax: +33 1 56 53 81 38


MitoGlobal


Listed as a MitoGlobal Society.

MitoGlobal         MitoEAGLE         MitoGlobal Societies         MiPsociety         ASMRM         MitoGlobal Events         MitoGlobal first


Cookies help us deliver our services. By using our services, you agree to our use of cookies.